Amgen and AstraZeneca announced results from the Phase 3 AMAGINE-2 study evaluating two doses of brodalumab in patients with moderate-to-severe plaque psoriasis.
According to a new Vital Signs report by the Centers for Disease Control and Prevention (CDC), only 30% of Americans with HIV had the virus under control in 2011, and about two-thirds of those with the virus not in control had been diagnosed but were no longer in care.
The Food and Drug Administration (FDA) is warning consumers to not buy or use Slim-Vie, a supplement marketed for weight loss.
The FDA has issued a warning about one patient with multiple sclerosis (MS) being treated with Tecfidera (dimethyl fumarate; Biogen Idec) who developed progressive multifocal leukoencephalopathy (PML) and later died.
As required by the 2010 Patient Protection and Affordable Care Act, the FDA finalized that calorie information be listed on menus and menu boards in chain restaurants, similar retail food establishments, and vending machines with 20 or more locations.